BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals BCRX
$ 7.51 0.6%

Quarterly report 2024-Q3
added 11-05-2024

report update icon

BioCryst Pharmaceuticals DPO Ratio 2011-2024 | BCRX

Annual DPO Ratio BioCryst Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.44 K 1.2 K 1.17 K 3.85 K 1.24 K 6.02 K 1.36 K 577 1.79 K 8.52 K 15.5 K 11 K -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
15.5 K 577 4.48 K

Quarterly DPO Ratio BioCryst Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
302 529 1.18 K - 1.02 K 1.03 K 1.01 K - 111 2.57 K 8.06 K - 2.3 K 3.63 K 248 - 1.13 K - - - - - 710 - - - - - 506 - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
8.06 K 111 1.62 K